期刊信息
主办:沈阳药科大学;中国药学会
主管:辽宁省教育厅
ISSN:1005-0108
CN:21-1313/R
语言:中文
周期:月刊
影响因子:0.190283
数据库收录:
文摘杂志;北大核心期刊(2017版);化学文摘(网络版);中国科学引文数据库(2011-2012);中国科学引文数据库(2013-2014);中国科学引文数据库(2015-2016);中国科学引文数据库(2017-2018);中国科学引文数据库(2019-2020);日本科学技术振兴机构数据库;中国科技核心期刊;期刊分类:药学
期刊热词:
研究论文
几种药物抗弓形虫活性的检测(4)
【作者】网站采编
【关键词】
【摘要】[6] Zuther E, Johnson JJ, Haselkorn R, et al. Growth ofToxoplasmagondiiis inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase [J]. Proc Natl Acad Sci, 1999, 96: -. DOI: 1
[6] Zuther E, Johnson JJ, Haselkorn R, et al. Growth ofToxoplasmagondiiis inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase [J]. Proc Natl Acad Sci, 1999, 96: -. DOI: 10.1073/
[7] D’angelo JG, Bordon C, Posner GH, et al. Artemisinin derivatives inhibitToxoplasmagondiiin vitro at multiple steps in the lytic cycle [J]. J Antimicrob Chemother, 2009, 63:146-150. DOI: 10.1093/jac/dkn451
[8] Saito H, Murata Y, Nonaka M, et al. Screening of a library of traditional Chinese medicines to identify compounds and extracts which inhibitToxoplasmagondiigrowth [J]. J Vet Med Sci, 2020,82(2):184-187. DOI: 10.1292/ DOI: 10.1292/
[9] Estes R, Vogel N, Mack D, et al. Paclitaxel arrests growth of intracellularToxoplasmagondii[J]. Antimicrob Agents chemother, 1998,42:2036-2040. DOI: 10.1128/
[10] Marc-Jan G, Catherine L, Boris S. High-throughput Growth Assay forToxoplasmagondiiusing yellow fluorescent protein [J]. Antimicrob Agents Chemother, 2003, 47 (1), 309-316. DOI: 10.1128/
[11] Qian W, Wang H, Shan D, et al. Activity of several kinds of drugs againstNeosporacaninum[J]. Parasitol Int, 2015, 64(6): 597-602. DOI: 10.1016/
[12] Fouladvand M, Barazesh A, Tahmaseb I. Evaluation ofinvitroantileishmanial a ctivity of curcumin and its derivatives “gallium curcumin, indium curcumin and diacethyle curcumin” [J]. Eur Rev Med Pharmacol Sci, 2013, 17: 3306-3308.
[13] Shahiduzzaman M, Dyachenko V, Khalafalla RE, et al. Daugschies, effects of curcumin onCryptosporidiumparvuminvitro[J]. Parasitol Res, 2009, 105: 1155-1161. DOI: 10.1007/s00436-009-1535-5
[14] Dohutia C, Chetia D, Gogoi K, et al. Design, in silico andinvitroevaluation of curcumin analogues againstPlasmodiumfalciparum[J]. Exp Parasitol, 2017, 175: 51-58. DOI: 10.1016/
[15] Rangel-Castaeda IA, Hernández-Hernández JM, Pérez-Rangel A, et al. Amoebicidal activity of curcumin onEntamoebahistolytica trophozoites [J]. J Pharm Pharmacol, 2018, 70(3): 426-433. DOI: 10.1111/jphp.
[16] Asadpour M, Namazi F, Razavi SM, et al. Comparative efficacy of curcumin and paromomycin againstCryptosporidiumparvuminfection in a BALB/c model [J].Vet Parasitol, 2018, 250: 7-14. DOI: 10.1016/
[17] Akhtar F, Rizvi MM, Kar SK. Oral delivery of curcumin bound to chitosan nanoparticles curedPlasmodiumyoeliiinfected mice [J]. Biotechnol Adv, 2012, 30: 310-320. DOI: 10.1016/
[18] Amaral AC, Gomes LA, Silva JR, et al. Liposomal formulation of turmerone-rich hexane fractions from Curcuma longa enhances their antileishmanial activity [J]. Biomed Res Int, 2014, . DOI: 10.1155/2014/
[19] Ke OY, Krug EC, Marr JJ, et al. Inhibition of growth ofToxoplasmagondiiby qinghaosu and derivatives [J]. Antimicrob Agents Chemother, 1990, 34: 1961-1965. DOI: 10.1128/
[20] Mitchell SM, Zajac AM, Davis WL, et al. The effects of ponazuril on development of apicomplexansinvitro[J]. J Eukaryot Microbiol, 2005, 52: 231-235. DOI: 10.1111/
ORCID: 0000-0002-4345-0090
文章来源:《中国药物化学杂志》 网址: http://www.zgywhxzz.cn/qikandaodu/2021/0622/589.html
上一篇:民国年间云南瘴疟防治考述
下一篇:冠心病介入治疗术后造影剂肾病的药物防治进展